| PD04217903 |
2-[4-[1-(喹啉-6-甲基)-1H-[1,2,3]三唑并[4,5-B]吡嗪-6-基]-1H-吡唑-1-基]乙醇 |
956905-27-4 |
| SCH772984 |
(R)-1-(2--2-氧(4-(4-(嘧啶-2-基)苯基)对二氮己环-1-基)乙基)-N-(3-(吡啶-4-基)-1H--5INDAZOL-基)吡咯烷-3-甲酰胺 |
942183-80-4 |
| Ibrutinib |
依鲁替尼 |
936563-96-1 |
| N-(1,1-Dimethylethyl)-3-[[5-methyl-2-[[4-(4-methyl-1-piperazinyl)phenyl]amino]-4-pyrimidinyl]amino]benzenesulfonamide |
N-(1,1-二甲基乙基)-3-[[5-甲基-2-[[4-(4-甲基-1-哌嗪基)苯基]氨基]-4-嘧啶基]氨基]苯磺酰胺 |
936091-14-4 |
| LY2603618 |
LY2603618 |
911222-45-2 |
| S(-)-BAY K 8644 |
(S)-(-)-BAY-K-8644 |
98625-26-4 |
| Zatebradine |
扎替雷定 |
85175-67-3 |
| MLN-120B |
N-(6-氯-7-甲氧基-9H-吡啶并[3,4-B]吲哚-8-基)-2-甲基-3-吡啶甲酰胺 |
783348-36-7 |
| PF-562271 |
N-甲基-N-[3-[[[2-[(2-氧代-2,3-二氢-1H-吲哚-5-基)氨基]-5-三氟甲基嘧啶-4-基]氨基]甲基]吡啶-2-基]甲磺酰胺 |
717907-75-0 |
| Methyl 1-aminocyclopropanecarboxylate hydrochloride |
1-氨基环丙烷甲酸甲酯盐酸盐 |
72784-42-0 |
| 1-Methyl-5-oxo-L-Proline |
1-METHYL-5-OXO-L-PROLINE |
52574-06-8 |
| BOC-TRP-OME |
BOC-L-色氨酸甲酯 |
33900-28-6 |
| ALPHA-METHYL-P-[1-OXO-2-ISOINDOLINYL]-BENZENEACETIC ACID |
茚酮苯丙酸 |
31842-01-0 |
| PD 173074 |
PD173074 |
219580-11-7 |
| Tazemetostat (EPZ-6438) |
EPZ-6438 |
1403254-99-8 |
| 1-Cyclopentyl-N-((4,6-diMethyl-2-oxo-1,2-dihydropyridin-3-yl)Methyl)-6-(4-(MorpholinoMethyl)phenyl)-1H-indazole-4-carboxaMide |
EPZ005687 |
1396772-26-1 |
| BRD4770 |
2-苯甲酰胺基-1-(3-苯丙基)-1H-苯并[D]咪唑-5-羧酸甲酯 |
1374601-40-7 |
| LOXO-101 |
拉罗替尼 |
1223403-58-4 |
| LDC1267 |
LDC1267 |
1361030-48-9 |
| GSK 343 |
GSK343 |
1346704-33-3 |
